Old Web
English
Sign In
Acemap
>
authorDetail
>
Nicholas Webb
Nicholas Webb
Novartis
Medicine
Alternative complement pathway
Complement factor B
Diabetes mellitus
glomerular disease
3
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FC 036IPTACOPAN (LNP023): A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FACTOR B INHIBITOR SAFELY AND EFFECTIVELY STABILISES EGFR IN C3 GLOMERULOPATHY
2021
Nephrology Dialysis Transplantation
Edwin Kwan Soon Wong
Manuel Praga
Carla M. Nester
Moglie Le Quintrec
Erica Daina
Giuseppe Remuzzi
Angelo J. Trapani
Yaqin Wang
Junhao Liu
Guido Junge
Matthias Meier
Nicholas Webb
Show All
Source
Cite
Save
Citations (1)
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.
2020
American Journal of Respiratory and Critical Care Medicine
Wioleta M. Zelek
Jade M. Cole
Mark J. Ponsford
Richard Harrison
Ben E Schroeder
Nicholas Webb
Stephen Jolles
Christopher Fegan
Matt Morgan
Matt P. Wise
B. Paul Morgan
Show All
Source
Cite
Save
Citations (20)
MO042LNP023: A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FACTOR B INHIBITOR FOR THE TREATMENT OF GLOMERULAR DISEASE
2020
Nephrology Dialysis Transplantation
Nicholas Webb
Boerje Haraldsson
Anna Schubart
Julie Milojevic
Peter End
Thomas Holbro
Guido Junge
Show All
Source
Cite
Save
Citations (0)
1